This site is intended for healthcare professionals only
LoginRegister
Aurobindo Pharmas subsidiary CuraTeQ Biologics Secures MHRA Approval for Trastuzumab Biosimilar Dazublys in HER2-Positive CancerAurobindo Pharma arm buys Ace Lab for Rs 17.91 crore
Delhi to form special committee to crush fake medicine racketOver 36 percent of inspected drug-making units had to be shut: CDSCO chief
Govt extends deadline for submitting applications under PLI SchemeBoosting local manufacturing: India plans incentives for diabetes, obesity drug makers in 2026
Novartis, Arrowhead strike upto USD 2 billion deal for neuromuscular therapy licenseOrchid Pharma collaborates with Cipla to unveil antibiotic Cefepime-Enmetazobactam in India
Roche receives EU CE mark for Contivue for neovascular age-related macular degenerationRoche Vabysmo gets CHMP recommendation for third indication retinal vein occlusion
Sun Pharma Secures Interim Court Relief In URSOCOL Trademark DisputeSun Pharma Laboratories Gets CDSCO Panel Nod To study Antidiabetic FDC Drug
Alembic Pharma wins USFDA approval for pulmonary arterial hypertension drug MacitentanAlembic Pharma secures USFDA okay for Doxycycline Capsules for inflammatory lesions of rosacea
Novartis, Argo Biopharma expand strategic alliance with USD 5.2 billion Cardiovascular drugs dealCDSCO Panel Approves Novartis Protocol Amendment Proposal To Study Ianalumab
USFDA concludes inspection at Zydus Lifesciences SEZ II, Ahmedabad plantJubilant Ingrevia receives USFDA EIR for Baruch facility
Lupin receives USFDA observations for two Pithampur manufacturing UnitsLupin bags USFDA tentative nod for Olopatadine Hydrochloride Ophthalmic Solution(OTC)
AbbVie seeks USFDA nod for combination regimen of Venclexta, AcalabrutinibUSFDA issues complete response letter for Patritumab Deruxtecan in EGFR-Mutated NSCLC: Merck,...
Zydus Lifesciences Reports Rs 6,573.7 Cr Revenue in Q1 FY26, Net Profit Rises 3%Zydus Life science's anticancer drug Pertuzumab Gets CDSCO Panel Nod for Additional Indication of...
X